CCLD
CCLD
CareCloud, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $34.42M ▲ | $-2.1M ▼ | $2.89M ▼ | 8.39% ▼ | $0.04 ▼ | $8.98M ▲ |
| Q3-2025 | $31.07M ▲ | $11.63M ▲ | $3.06M ▲ | 9.85% ▼ | $0.04 | $7.33M ▲ |
| Q2-2025 | $27.38M ▼ | $9.9M ▼ | $2.9M ▲ | 10.6% ▲ | $0.04 ▲ | $6.46M ▲ |
| Q1-2025 | $27.63M ▼ | $10.15M ▲ | $1.95M ▼ | 7.05% ▼ | $-0.04 ▼ | $5.45M ▼ |
| Q4-2024 | $28.24M | $9.78M | $3.3M | 11.67% | $0 | $6.66M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $3.12M ▼ | $87.6M ▼ | $28.09M ▼ | $59.51M ▲ |
| Q3-2025 | $5.07M ▼ | $90.58M ▲ | $32.77M ▲ | $57.8M ▲ |
| Q2-2025 | $10.44M ▲ | $75.24M ▲ | $19.17M ▼ | $56.08M ▲ |
| Q1-2025 | $6.8M ▲ | $73.56M ▲ | $19.38M ▼ | $54.18M ▲ |
| Q4-2024 | $5.14M | $71.61M | $21.84M | $49.77M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $2.89M ▼ | $8.68M ▲ | $-3.33M ▲ | $-6.84M ▼ | $-1.46M ▲ | $11.33M ▲ |
| Q3-2025 | $3.06M ▲ | $7.37M ▼ | $-17.7M ▼ | $4.92M ▲ | $-5.37M ▼ | $6.5M ▲ |
| Q2-2025 | $2.9M ▲ | $7.41M ▲ | $-1.99M ▼ | $-1.76M ▲ | $3.63M ▲ | $6.25M ▲ |
| Q1-2025 | $1.95M ▼ | $5.11M ▼ | $-1.51M ▲ | $-1.93M ▼ | $1.66M ▼ | $4.49M ▲ |
| Q4-2024 | $3.3M | $5.23M | $-2.26M | $-578K | $2.36M | $4.29M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q4-2025 |
|---|---|---|---|---|
Remote Patient Monitoring | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Revenue Cycle Management | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at CareCloud, Inc.'s financial evolution and strategic trajectory over the past five years.
CareCloud combines positive profitability with strong cash generation and low financial leverage, giving it room to invest and absorb shocks. Its integrated, cloud‑based platform and AI‑driven tools provide a clear strategic identity in healthcare IT. A conservative balance sheet, adequate liquidity, and a cost‑efficient dual‑shore model further support its ability to fund innovation and acquisitions without leaning heavily on debt.
Key risks include a balance sheet loaded with goodwill and intangibles, which could be impaired if acquisitions disappoint, and negative retained earnings that highlight a history of cumulative losses before recent profitability. Operating expenses, especially overhead, remain high relative to revenue, leaving less margin for error if growth slows. Competitive and regulatory pressures in healthcare IT, plus execution challenges around integrating acquisitions and scaling AI responsibly, could also weigh on future performance.
The overall picture is of a mid‑sized, innovation‑oriented healthcare IT company that has recently turned a corner into consistent profitability and strong cash generation, supported by a conservative capital structure. If it can sustain revenue growth, keep operating costs in check, successfully integrate acquisitions, and convert its AI initiatives into real customer value, its financial profile could gradually strengthen. However, with only one year of detailed data, limited visibility into long‑term trends, and meaningful execution and competitive risks, the forward outlook should be viewed as cautiously constructive rather than assured.
About CareCloud, Inc.
https://www.carecloud.comCareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $34.42M ▲ | $-2.1M ▼ | $2.89M ▼ | 8.39% ▼ | $0.04 ▼ | $8.98M ▲ |
| Q3-2025 | $31.07M ▲ | $11.63M ▲ | $3.06M ▲ | 9.85% ▼ | $0.04 | $7.33M ▲ |
| Q2-2025 | $27.38M ▼ | $9.9M ▼ | $2.9M ▲ | 10.6% ▲ | $0.04 ▲ | $6.46M ▲ |
| Q1-2025 | $27.63M ▼ | $10.15M ▲ | $1.95M ▼ | 7.05% ▼ | $-0.04 ▼ | $5.45M ▼ |
| Q4-2024 | $28.24M | $9.78M | $3.3M | 11.67% | $0 | $6.66M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $3.12M ▼ | $87.6M ▼ | $28.09M ▼ | $59.51M ▲ |
| Q3-2025 | $5.07M ▼ | $90.58M ▲ | $32.77M ▲ | $57.8M ▲ |
| Q2-2025 | $10.44M ▲ | $75.24M ▲ | $19.17M ▼ | $56.08M ▲ |
| Q1-2025 | $6.8M ▲ | $73.56M ▲ | $19.38M ▼ | $54.18M ▲ |
| Q4-2024 | $5.14M | $71.61M | $21.84M | $49.77M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $2.89M ▼ | $8.68M ▲ | $-3.33M ▲ | $-6.84M ▼ | $-1.46M ▲ | $11.33M ▲ |
| Q3-2025 | $3.06M ▲ | $7.37M ▼ | $-17.7M ▼ | $4.92M ▲ | $-5.37M ▼ | $6.5M ▲ |
| Q2-2025 | $2.9M ▲ | $7.41M ▲ | $-1.99M ▼ | $-1.76M ▲ | $3.63M ▲ | $6.25M ▲ |
| Q1-2025 | $1.95M ▼ | $5.11M ▼ | $-1.51M ▲ | $-1.93M ▼ | $1.66M ▼ | $4.49M ▲ |
| Q4-2024 | $3.3M | $5.23M | $-2.26M | $-578K | $2.36M | $4.29M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q4-2025 |
|---|---|---|---|---|
Remote Patient Monitoring | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Revenue Cycle Management | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at CareCloud, Inc.'s financial evolution and strategic trajectory over the past five years.
CareCloud combines positive profitability with strong cash generation and low financial leverage, giving it room to invest and absorb shocks. Its integrated, cloud‑based platform and AI‑driven tools provide a clear strategic identity in healthcare IT. A conservative balance sheet, adequate liquidity, and a cost‑efficient dual‑shore model further support its ability to fund innovation and acquisitions without leaning heavily on debt.
Key risks include a balance sheet loaded with goodwill and intangibles, which could be impaired if acquisitions disappoint, and negative retained earnings that highlight a history of cumulative losses before recent profitability. Operating expenses, especially overhead, remain high relative to revenue, leaving less margin for error if growth slows. Competitive and regulatory pressures in healthcare IT, plus execution challenges around integrating acquisitions and scaling AI responsibly, could also weigh on future performance.
The overall picture is of a mid‑sized, innovation‑oriented healthcare IT company that has recently turned a corner into consistent profitability and strong cash generation, supported by a conservative capital structure. If it can sustain revenue growth, keep operating costs in check, successfully integrate acquisitions, and convert its AI initiatives into real customer value, its financial profile could gradually strengthen. However, with only one year of detailed data, limited visibility into long‑term trends, and meaningful execution and competitive risks, the forward outlook should be viewed as cautiously constructive rather than assured.

CEO
Stephen A. Snyder
Compensation Summary
(Year )
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 3 of 21
Ratings Snapshot
Rating : B
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:1.66M
Value:$5.08M
AMERIPRISE FINANCIAL INC
Shares:1.62M
Value:$4.95M
HILLSDALE INVESTMENT MANAGEMENT INC.
Shares:804.51K
Value:$2.45M
Summary
Showing Top 3 of 82

